Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Treatment of early stage cervical and ovarian cancer

Choosing Wisely: Value added cancer care for India

15 - 16 Oct 2019

Published: 20 Feb 2020

Views: 1119

Rating:

Save

Dr Rama Joshi - Foirtis Memorial Research Institute, Gurgaon, India

Dr Rama Joshi presents a talk on 'Treatment of early stage cervical and ovarian cancer' at the Choosing wisely: Value Added Cancer Care for India event in New Delhi.

Related Videos

Innovating cancer care access for low and middle-income countries

Lacy Hubbard - Founding President and CEO, Elekta Foundation

Innovating cancer care access for low and middle-income countries ( Lacy Hubbard - Founding President and CEO, Elekta Foundation )

Innovation in cancer treatment and equity: ensuring emerging treatments reach all populations

Dr Dario Trapani - European Institute of Oncology, IRCCS, Milan, Italy

Innovation in cancer treatment and equity: ensuring emerging treatments reach all populations ( Dr Dario Trapani - European Institute of Oncology, IRCCS, Milan, Italy )

Prostate cancer

Dr Alison Tree - Institute of Cancer Research, London, UK

Prostate cancer ( Dr Alison Tree - Institute of Cancer Research, London, UK )

Rectal cancer

Dr Rebecca Wong - Princess Margaret Cancer Center, Toronto, Canada

Rectal cancer ( Dr Rebecca Wong - Princess Margaret Cancer Center, Toronto, Canada )

Gender inequity in ovarian cancer research in resource limited settings

Dr Khalid El Bairi - Mohamed First University, Oujda, Morocco

Gender inequity in ovarian cancer research in resource limited settings ( Dr Khalid El Bairi - Mohamed First University, Oujda, Morocco )

Synthetic biology and precision medicine in blood and gynaecological cancers

Dr Mutsa Takundwa - Council for Scientific and Industrial Research, Pretoria, South Africa

Synthetic biology and precision medicine in blood and gynaecological cancers ( Dr Mutsa Takundwa - Council for Scientific and Industrial Research, Pretoria, South Africa )

Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC

Dr Shirish Gadgeel - Henry Ford Cancer Institute, Detroit, USA

Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC ( Dr Shirish Gadgeel - Henry Ford Cancer Institute, Detroit, USA )

OncoAlert Round Up for September 15-21, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert Round Up for September 15-21, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

NSIA and Nigeria to improve treatment for Nigerians through the building of new cancer centres

Aminu Umar-Sadiq - MD & CEO, Nigeria Sovereign Investment Authority (NSIA)

NSIA and Nigeria to improve treatment for Nigerians through the building of new cancer centres ( Aminu Umar-Sadiq - MD & CEO, Nigeria Sovereign Investment Authority (NSIA) )

More from ecancer